Abstract

Omeprazole (Prilosec) in the Atypical Patient, Administration of

Author(s): Kane Dana Lynn

Issue: Jan/Feb 1997 - Hospice Care

Page(s): 13

Download in electronic PDF format for $75
  • Omeprazole (Prilosec) in the Atypical Patient, Administration of Page 1

Abstract

Omeprazole, a proton pump inhibitor indicated for peptic ulcer disease, reflux esophagitis and hypersecretory conditions, is known to be inactivated by gastric acidity. In this article, the author provides suggestions for administering omeprazole to a patient who cannot swallow the capsule whole or who has a nasogastric or gastrostomy tube or a jejunostomy tube.

Related Keywords

  • Enteric
  • Gastrotomy
  • Jejunostomy
  • Nasogastric
  • ph
  • Prilosec
  • Stomach
  • Tube

Related Categories

  • FORMULATIONS
  • GERIATRICS
  • PEDIATRICS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 1997
Pg. 13
Omeprazole (Prilosec) in the Atypical Patient, Administration of
Author(s): Kane Dana Lynn
May/Jun 2022
Pg. 214-217
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 250-256
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
Author(s): de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
Jul/Aug 2010
Pg. 276-282
Recommendations for Compounding Medications for Feeding Tube Administration
Author(s): Klang Mark
Sep/Oct 2006
Pg. 383
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Author(s): Allen Loyd V Jr
Jul/Aug 2000
Pg. 304
Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 206-207
Technology Spotlight: Tube Sealers
Author(s): Jones Michael, Adams Susan
Mar/Apr 2008
Pg. 163-169
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
Author(s): de Oliveira Ferreira Anderson, Holandino Carla
May/Jun 2009
Pg. 250-253
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Author(s): Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
Sep/Oct 2006
Pg. 389
Omeprazole 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
Jul/Aug 2003
Pg. 258-263
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
Author(s): DiMaggio Jennifer Lyn, Reed-Kane Dana
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 224-229
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
Author(s): McElhiney Linda F
Jul/Aug 2013
Pg. 270-280
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 339-343
Patient-centered Care as Value-added Service by Compounding Pharmacists
Author(s): McPherson Timothy B, Fontane Patrick E, Day Jonathan R
Mar/Apr 2012
Pg. 164-166
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Author(s): Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
Jan/Feb 2018
Pg. 30-39
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
Author(s): McElhiney Linda F
Jan/Feb 2019
Pg. 58
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Author(s): Allen Loyd V Jr